Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ostave-Forte is a nutritional supplement marketed by Octave Life Sciences. It is formulated as oral tablets containing a combination of calcium citrate malate, vitamin D3 (cholecalciferol), magnesium, and zinc sulfate. This combination is designed to address nutritional deficiencies, support bone mineralization, and maintain overall musculoskeletal health. Calcium citrate malate provides a highly bioavailable source of calcium, while vitamin D3 facilitates its absorption. Magnesium and zinc serve as essential cofactors in bone metabolism and enzymatic processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ostave-Forte.